Related Experiment Video
Updated: Jan 29, 2026

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro
Letizia Mattii1, Carla Pardini2, Chiara Ippolito3
1Department of Clinical and Experimental Medicine, Unit of Histology, via Roma 55, University of Pisa, 56126 Pisa, Italy; Interdepartmental Research Center Nutraceuticals and Food for Health, University of Pisa, 56124 Pisa, Italy.
Abstract:
Mesencephalic cell cultures are a good model to study the vulnerability of dopaminergic neurons and reproduce, in vitro, experimental models of Parkinson's disease. Rotenone associated as an environmental neurotoxin related to PD, is able to provoke dopaminergic neuron degeneration by inhibiting complex I of the mitochondrial respiratory chain and by inducing accumulation of α-synuclein. Recently, rotenone has been described to activate RhoA, a GTPase protein. In the present study we evaluated a possible neuroprotective effect of Rho-inhibitor molecules on rotenone-damaged dopaminergic (DA) neurons obtained from mouse primary mesencephalic cell culture. Our results showed that Clostridium Botulinum C3 toxin (C3) and simvastatin, as RhoA inhibitors, were able to protect DA neurons from rotenone damages. In fact, pretreatment with C3 or simvastatin significantly prevented the reduction of [3H]dopamine uptake, neurites injury and the expression patterns of proteins like α-syn, actin and connexin 43.
More Related Videos
06:17Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans
Published on: November 20, 2021
07:33Organotypic Slice Cultures of Embryonic Ventral Midbrain: A System to Study Dopaminergic Neuronal Development in vitro
Published on: January 31, 2012
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Feedback Inhibition
Cell Polarization by Rho Proteins
Enzyme Inhibition
Inhibition of Cdk Activity
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy